Navigation Links
FDA Approves First-of-its-Kind Drug to Treat Rare Blood Disorder

ilization of blood hemoglobin concentrations compared with no stabilization among placebo-treated patients. Soliris-treated patients also required significantly fewer blood transfusions.

Soliris' blockade of the body's natural immune system increases the patient's susceptibility to certain serious infections, particularly meningococcal infections that can cause bacterial meningitis, an infection of the tissue surrounding the spinal cord and brain. Serious meningococcal infection was the most important adverse reaction experienced by patients who received Soliris in clinical studies. Because of the high risk for serious meningococcal infections, all 196 PNH patients in the clinical studies were vaccinated with a meningococcal vaccine; two of them developed meningococcal sepsis (an infection of the bloodstream caused by meningococcal bacteria) during treatment with Soliris.

A special risk management plan for Soliris has been developed to address the risk of serious meningococcal infection. The labeling of the product contains a boxed warning and requires that patients receive meningococcal vaccination prior to receiving Soliris. The labeling also includes a Medication Guide for patients. In addition, the risk management plan includes an educational program for physicians.

Orphan products are developed to treat rare diseases or conditions that affect fewer than 200,000 people in the United States. The Orphan Drug Act provides a seven-year period of exclusive marketing to the first manufacturer who obtains marketing approval for a designated orphan product. About one person out of a million people will be diagnosed with PNH.

Source-Bio-Bio Technology
'"/>




Page: 1 2

Related medicine news :

1. FDA Approves Contraceptive Ring
2. FDA Approves New HIV Drug, Viread
3. FDA Approves Birth Control Skin Patch
4. FDA Approves New Arthritis Drug, Bextra
5. FDA Approves Elidel Cream for Eczema
6. FDA Approves New Anti-Clotting Drug
7. FDA Approves New surgery Treatment for Farsightedness
8. FDA Approves Anti-Cancer Cell Drug - Zevalin
9. FDA Approves Remodulin for Pulmonary Hypertension
10. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
11. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: FDA Approves First its Kind Drug Treat Rare Blood Disorder

(Date:8/1/2015)... ... August 01, 2015 , ... Western University of ... profession” that comprises a growing percentage of U.S. physicians, and reflects the diversity ... one part of the message delivered by John W. Becher, DO, president of ...
(Date:8/1/2015)... ... , ... Tina Wilcoxson, owner of Freeport Maine’s Royal River Natural Foods, was ... National Retail Federation, the largest retail trade association in the world, for her “advocacy ... to be named as such. According to the NRF’s website, Retail Champions are “Main ...
(Date:8/1/2015)... , ... August 01, 2015 , ... Lume Wellness creators ... is free to download on the Apple AppStore. , The app is designed ... mood, thus acting as a tool to view personal health and use this information ...
(Date:7/31/2015)... Rosa, CA (PRWEB) , ... July 31, 2015 ... ... posted by High Times magazine. What are the STASH awards? The Significant ... advances made by the cannabis-cultivation community as well as tried-and-true products that have ...
(Date:7/31/2015)... ... , ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA ... the Super Bowl. In the two weeks that separate the conference championships and the Super ... Super Bowl game will mark the 50th time it has been held and the festivities ...
Breaking Medicine News(10 mins):Health News:COMP-Northwest Welcomes Class of 2019 2Health News:COMP-Northwest Welcomes Class of 2019 3Health News:COMP-Northwest Welcomes Class of 2019 4Health News:COMP-Northwest Welcomes Class of 2019 5Health News:Local Retail Advocate Wins National Recognition 2Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2
... ATLANTA, Oct. 30 Even though many hospitals ... automate their surgery,processes, those that do see significant ... care. A case study recently,published by Kermit Randa ... The Work Group, Inc., outlines the benefits realized ...
... (NYSE:,HRC) today announced a new agreement with Encompass ... Quantum(TM) VPC Support,Systems for use with Hill-Rom(R) bed ... in our relationship with Encompass,",said Mary Butler, executive ... Hill-Rom. "This agreement is part of our focus ...
... in Emerging Food Processing Market for SDC, ... today announced that the United States Patent and ... process for treating,consumable food products with silver dihydrogen ... new patent expands the scope of,protection of PURE,s ...
... adds Women,s Hospital to Growing List of New Breast ... Inc. (Pink,Sheets: SNDY) is pleased to announce that the ... purchased and are now in use,at the Women,s Hospital ... employs advanced micro endoscopes and optical technology to,give physicians ...
... to acid in the mouth is the culprit, pediatric dentist ... its avalanche of candy is coming, making it the worst ... says a dentist who contends that parents can make a ... , "Parents need to know that frequency is far ...
... Cancidas and Astellas,s Mycamine Cut Prices, According To New Data ... from Arlington Medical Resources, ... of premier market intelligence for the pharmaceutical and,diagnostic imaging industries, finds ... classes: 10.7 percent of all courses,in the January - June 2008 ...
Cached Medicine News:Health News:Healthcare Providers Improve Financial, Clinical and Operational Efficiencies Through IT 2Health News:Hill-Rom Announces Agreement with Encompass Therapeutic Support Systems Adding New Surface Choice for Use with Hill-Rom Frames 2Health News:Hill-Rom Announces Agreement with Encompass Therapeutic Support Systems Adding New Surface Choice for Use with Hill-Rom Frames 3Health News:PURE Bioscience Granted US Patent on SDC for Food Treatment 2Health News:PURE Bioscience Granted US Patent on SDC for Food Treatment 3Health News:Solos Endoscopy, Inc.'s Mammo View(TM) System Now Used in Women's Hospital of Baton Rouge, LA 2Health News:Halloween Candy: It's Not How Much Kids Eat, It's When 2Health News:Halloween Candy: It's Not How Much Kids Eat, It's When 3Health News:Echinocandins Show Growth Among All Antifungal Classes 2Health News:Echinocandins Show Growth Among All Antifungal Classes 3
(Date:7/31/2015)... WOODCLIFF LAKE, N.J. and SAN ... announced today that its parent company Eisai Co., Ltd. ... Haruo Naito , "Eisai") and Halozyme Therapeutics, Inc. ... and CEO: Dr. Helen Torley , "NASDAQ: HALO") ... eribulin mesylate (brand name: Halaven ® , "eribulin") in ...
(Date:7/30/2015)... Calif. , July 30, 2015 Edwards Lifesciences ... science of heart valves and hemodynamic monitoring, today announced that ... Board of Directors. "Bob is an ardent champion ... a true privilege to have him on Edwards, board as ... Mussallem , Edwards, chairman and CEO.  "Bob has provided a ...
(Date:7/30/2015)... Inc. (NYSE: RMD ) today announced results for ... quarter was $453.1 million, a 9 percent increase compared ... percent increase on a constant currency basis).  Net income ... 30, 2014.  Diluted earnings per share for the quarter ... 2014.  The results for the quarter ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
... ARAY ), a global leader in the field ... officer, Euan S. Thomson, Ph.D., is scheduled to present at ... on Monday, January 10, 2011 at 2:30 p.m. PT/5:30 p.m. ... be available online from the investor relations page of the ...
... Sinovac Biotech Ltd. (Nasdaq: SVA ), a ... that it received approval from the China State Food ... its proprietary inactivated EV71 vaccine against Hand, Foot and ... is required to conduct each phase of the human ...
Cached Medicine Technology:Accuray Incorporated's CEO to Speak at 29th Annual J.P. Morgan Healthcare Conference 2Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine 2Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine 3Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine 4
MAGNETOM Symphony, an imaging system that offers 1.5T performance and top image quality in a short bore design....
... MAGNETOM Trio with Tim™ (Total ... workflow, highest speed, and highest resolution ... up to 16, advanced applications can ... routine. MAGNETOM Trio with Tim is ...
... It enables you to scan every beating heart ... radiation dose possible. A scanner using two ... time. It provides one-stop diagnosis in acute care; ... heart rate. Combined with the Cardiac Engine, a ...
... Assistant (MBA) is a Microsoft ... practice management software package. MBA ... Server technology and is HIPAA ... account receivable management, MBA allows ...
Medicine Products: